Skip to content
Discover the best of London with insider tips, cultural ins…

The Zimbabwean Government Turns Down ‘Lopsided’ US Healthcare Assistance Deal Over Information Fears

Medical funding illustration
The proposed US financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a substantial US health deal worth 367 million US dollars (£272m) spanning five years over Washington's request for confidential data.

The decision became public following a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the agreement was "skewed".

An official representative later stated that the United States was seeking genetic material for research and profit but was unwilling to guarantee the benefits from future vaccines.

"We will now turn to the difficult and regrettable process of scaling back our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has called for continued negotiations to secure a agreement acceptable to both sides so the country's critical HIV treatment initiative can proceed.

Broader Context

This development comes after a comparable case in Kenya, where a high court halted a related deal with the US following legal challenges were raised about the safety of Kenyans' health data.

After resuming office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).

USAID had managed assistance for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost transparency and responsibility.

As per statements, Sixteen African countries have so far signed similar health pacts, representing more than $18.3bn in new funding.

Details of the Declined Agreement

The money for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this cooperation could have provided significant benefits for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment through American-funded programmes," Tremont said.

However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, with no equivalent guarantee of access to any medical innovations – like new medicines or tests – that might result from that shared data," his statement read.

"Put simply, our nation would supply the raw materials for scientific discovery with no assurance that the end products would be accessible to our citizens should a future health crisis arise."

National Interest and International Frameworks

Mangwana further noted that the US's withdrawal from the global health body and its pursuit of one-on-one deals were undermining frameworks previously established via the global health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.

"This framework is designed to guarantee that when a nation contributes its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," he added.

"We are open to continued discussions with our US partners on how future co-operation might be arranged in a manner that honours the independence and dignity of each country."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but urged that talks need to persist given that a large portion of the country's HIV programmes were funded by external financing.

"If technical issues exist, including those relating to data governance or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," it said.

The halted deal emphasises the complex tensions between receiving crucial international aid and safeguarding a country's data in an ever more interconnected world.

The writer

Brenda Mckenzie

Elena Hart is a British travel writer and London enthusiast with over a decade of experience uncovering the city's secrets.

London Journal

Type to search articles.